NSE filing, NSE: ZOTA. Summary written from the filing by ALFA Finder's alert engine.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,270.00
- Market cap
- ₹4,398 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -42.6×Sector 46.5×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 6.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Results Update
Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.
Zota Healthcare Q2 FY27 Results: Net Loss of ₹26 Cr, Loss Widens
Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.
- Key figure
- Net loss ₹26 Cr
Zota Healthcare Price Movement Clarification
Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.
Zota Healthcare Business Update
Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.
- store expansion
- 20.0 stores
Zota Healthcare Capital Structure Change
Zota Health Care Limited acquired 21,00,000 equity shares of its subsidiary, KMHP Ventures Limited, for ₹2.10 Crore. This investment supports the expansion of the 'Ugo Generic' retail pharmacy chain.
- Value
- ₹2.10 Cr
Zota Healthcare Acquisition Worth ₹19.91 Cr
Zota Health Care Limited acquired 39,228 equity shares of its subsidiary, Davaindia Health Mart Limited, for Rs. 19.91 Crore. The investment was made via a rights issue subscription.
- Value
- ₹19.91 Cr
- pharmacy stores
- 1855.0 stores
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.